BrAin Metastasis in tripLe Negateive Breast Cancer: IvoneScimab and Trop2 ADC

Clinical trial NCT06793332 · RECRUITING

Trial details

NCT number: NCT06793332
Sponsor: Fudan University
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Triple-Negative Breast Cancer (TNBC)Brain Metastases

Start date: 2024-12-17
Primary completion: 2026-01-31
Enrollment: 39

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.